Similarly to other neoplasms, ovarian cancer is characterized by the loss of β-glycan expression, yet the role of activin pathway, and interactions among inhibins, activins and other components of TGF-β family, still remain unclear [15]. This evidence concerns the gene INHBE and neoplasm.